The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS
Open accessAbstract
Amyotrophic lateral sclerosis (ALS) is a progressive disease associated with neuronal cell death that is thought to involve aberrant immune responses. Here we investigated the role of innate immunity in a mouse model of ALS. We found that inflammatory monocytes were activated and that their progressive recruitment to the spinal cord, but not brain, correlated with neuronal loss. We also found a decrease in resident microglia in the spinal cord with disease progression. Prior to disease onset, splenic Ly6Chi monocytes expressed a polarized macrophage phenotype (M1 signature), which included increased levels of chemokine receptor CCR2. As disease onset neared, microglia expressed increased CCL2 and other chemotaxis-associated molecules, which led to the recruitment of monocytes to the CNS by spinal cord-derived microglia. Treatment with anti-Ly6C mAb modulated the Ly6Chi monocyte cytokine profile, reduced monocyte recruitment to the spinal cord, diminished neuronal loss, and extended survival. In humans with ALS, the analogous monocytes (CD14+CD16-) exhibited an ALS-specific microRNA inflammatory signature similar to that observed in the ALS mouse model, linking the animal model and the human disease. Thus, the profile of monocytes in ALS patients may serve as a biomarker for disease stage or progression. Our results suggest that recruitment of inflammatory monocytes plays an important role in disease progression and that modulation of these cells is a potential therapeutic approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“we found an increase in CD39−CD11bHi cells which express Ly6C (Fig. 7g) and which represent peripherally infiltrating monocytes9,12.”
From Identification of a unique TGF-β–dependent molecular and functional signature in microglia (2014) · cites this paper as [12]
The cited source says what the claim attributes to it.
In the citing paper
“We previously reported that CD39 is expressed on adult microglia and can distinguish recruited Ly6C+ monocytes from resident microglia12.”
From Identification of a unique TGF-β–dependent molecular and functional signature in microglia (2014) · cites this paper as [12]
In the citing paper
“peripheral macrophages that infiltrate motor axons during disease progression may also be neurotoxic (152)”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [152]
In the citing paper
“sialoadhesin (SIGLEC1; also known as CD169) is a marker for mature dendritic cells and macrophages in both mice and humans48 and has been proposed as a marker for invading monocyte-derived macrophages in the CNS as it is not expressed in microglia in health or disease49–52.”
From Microglial signatures and their role in health and disease (2018) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M. F., Conway, S. J., Ng, L. G., Stanley, E. R., et al. (2010) · Science · doi:10.1126/science.1194637 · Cited by 5,175
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936 · cited 2×
“It is now known that there are other forms of familial ALS-related mutations such as TDP-43 , FUS , and the newly discovered mutation in a noncoding region of C9ORF72 (79, 80) , which is the most common known genetic cause of fALS (46”
Toll-like receptors: critical proteins linking innate and acquired immunity
Akira, S., Takeda, K., & Kaisho, T. (2001) · Nature Immunology · doi:10.1038/90609 · Cited by 4,777
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
Taganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317
Blood Monocytes Consist of Two Principal Subsets with Distinct Migratory Properties
Geissmann, F., Jung, S., & Littman, D. R. (2003) · Immunity · doi:10.1016/s1074-7613(03)00174-2 · Cited by 3,504
MicroRNAs Modulate Hematopoietic Lineage Differentiation
Chen, C.-Z., Li, L., Lodish, H. F., & Bartel, D. P. (2004) · Science · doi:10.1126/science.1091903 · Cited by 3,257
Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D. J., Usheva, A., Erat, A., Chen, J., Enjyoji, K., Linden, J. M., Oukka, M., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062512 · Cited by 2,613
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
Ma, L., Teruya-Feldstein, J., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06174 · Cited by 2,605
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., Galuppo, P., Just, S., Rottbauer, W., Frantz, S., et al. (2008) · Nature · doi:10.1038/nature07511 · Cited by 2,349
Research works printed but not linked: 2
- Braun, 2000, Eur J Neurosci., 12, 4357
- Kulkarni, 2011, Curr Protoc Mol Biol., Chapter, Unit25B
Cited by
Sorted by citations
Items 201–300 of 481
The microbiota restrains neurodegenerative microglia in a model of amyotrophic lateral sclerosis
Cox, L. M., Calcagno, N., Gauthier, C., Madore, C., Butovsky, O., & Weiner, H. L. (2022) · Microbiome · doi:10.1186/s40168-022-01232-z · Cited by 53
Self-citationIncreased activation ability of monocytes from ALS patients
Du, Y., Zhao, W., Thonhoff, J. R., Wang, J., Wen, S., & Appel, S. H. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113259 · Cited by 54
Asai, H., Ikezu, S., Woodbury, M. E., Yonemoto, G., Cui, L., & Ikezu, T. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.11.026 · Cited by 49
MicroRNAs as Potential Circulating Biomarkers for Amyotrophic Lateral Sclerosis
Cloutier, F., Marrero, A., O’Connell, C. M., & Morin, P. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0471-8 · Cited by 52
M1 and M2 Functional Imprinting of Primary Microglia: Role of P2X7 Activation and miR-125b
Parisi, C., Napoli, G. D., Pelegrı́n, P., & Volonté, C. (2016) · Mediators of Inflammation · doi:10.1155/2016/2989548 · Cited by 51
The Role of MicroRNAs in Patients with Amyotrophic Lateral Sclerosis
Dardiotis, E., Aloizou, A., Siokas, V., Patrinos, G. P., Deretzi, G., Mitsias, P. D., Aschner, M., & Tsatsakis, A. M. (2018) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1204-1 · Cited by 50
Li, C., Ren, J., Zhang, M., Wang, H., Fang, Y., Wu, J., & Tang, Y. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04536-3 · Cited by 52
Chemical dampening of Ly6Chi monocytes in the periphery produces anti-depressant effects in mice
Zheng, X., Ma, S., An, K., Wu, M., Wang, L., Wang, Q., Wang, G., & Hao, H. (2016) · Scientific Reports · doi:10.1038/srep19406 · Cited by 48
Fellner, A., Barhum, Y., Angel, A., Perets, N., Steiner, I., Offen, D., & Lev, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081666 · Cited by 48
Decoding the Role of Platelets and Related MicroRNAs in Aging and Neurodegenerative Disorders
Espinosa‐Parrilla, Y., González-Billault, C. E., Eduardo Fuentes, Q., Palomo, I. F., & Alarcón, M. A. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00151 · Cited by 50
Monocytes and neutrophils are associated with clinical features in amyotrophic lateral sclerosis
McGill, R., Steyn, F. J., Ngo, S. T., Thorpe, K., Heggie, S., Ruitenberg, M. J., Henderson, R. D., McCombe, P., & Woodruff, T. M. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa013 · Cited by 47
Origin and Emergence of Microglia in the CNS—An Interesting (Hi)story of an Eccentric Cell
Dermitzakis, I., Μanthou, M. E., Meditskou, S., Tremblay, M., Petratos, S., Zoupi, L., Boziki, M. K., Kesidou, E., Simeonidou, C., & Theotokis, P. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45030171 · Cited by 55
Hosaka, T., Yamashita, T., Tamaoka, A., & Kwak, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133148 · Cited by 49
Amyotrophic lateral sclerosis: The complement and inflammatory hypothesis
Kjældgaard, A.-L., Pilely, K., Olsen, K. S., Pedersen, S. W., Lauritsen, A. Ø., Møller, K., & Garred, P. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.06.007 · Cited by 45
Neuroinflammation in amyotrophic lateral sclerosis: pathogenic insights and therapeutic implications
Calma, A. D., Pavey, N., Menon, P., & Vucic, S. (2024) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001279 · Cited by 48
Role and Dysregulation of miRNA in Patients with Parkinson’s Disease
Salemi, M., Marchese, G., Lanza, G., Cosentino, F., Salluzzo, M. G., Schillaci, F. A., Ventola, G. M., Cordella, A., Ravo, M., & Ferri, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010712 · Cited by 47
Abou‐El‐Hassan, H., Rezende, R. M., Izzy, S., Gabriely, G., Yahya, T., Tatematsu, B. K., Habashy, K. J., Lopes, J. R., de Oliveira, G. L. V., Maghzi, A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39857-9 · Cited by 45
Self-citationEpigenetic Mechanisms of Gene Regulation in Amyotrophic Lateral Sclerosis
Jimenez‐Pacheco, A., Franco, J. M., Lopez, S., Gómez‐Zumaquero, J. M., Leal‐Lasarte, M., Caballero-Hernández, D. E., Cejudo‐Guillén, M., & Pozo, D. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-53889-1_14 · Cited by 46
Zhang, D., Kirby, L. A., Lin, Y., Song, M., Wang, L., Wang, L., Kanatani, S., Jimenez-Beristain, T., Dang, Y., Zhong, M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.28.605493 · Cited by 45
Infiltration of circulating myeloid cells through CD95L contributes to neurodegeneration in mice
Gao, L., Brenner, D., Llorens-Bobadilla, E., Saiz-Castro, G., Frank, T., Wieghofer, P., Hill, O., Thiemann, M., Karray, S., Prinz, M., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20132423 · Cited by 42
Macro roles for microRNAs in neurodegenerative diseases
Rajgor, D. (2018) · Non-coding RNA Research · doi:10.1016/j.ncrna.2018.07.001 · Cited by 47
Verheijden, S., Beckers, L., Casazza, A., Butovsky, O., Mazzone, M., & Baes, M. (2015) · Glia · doi:10.1002/glia.22831 · Cited by 40
Self-citationAzam, H. M. H., Rößling, R., Geithe, C., Khan, M. M., Dinter, F., Hanack, K., Prüß, H., Husse, B., Roggenbuck, D., Schierack, P., et al. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1386735 · Cited by 49
MicroRNAs: Newcomers into the ALS Picture
Volonté, C., Apolloni, S., & Parisi, C. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527314666150116125506 · Cited by 43
Christoforidou, E., Joilin, G., & Hafezparast, M. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01822-4 · Cited by 44
Use of biomarkers in ALS drug development and clinical trials
Bakkar, N., Boehringer, A. V., & Bowser, R. P. (2014) · Brain Research · doi:10.1016/j.brainres.2014.10.031 · Cited by 43
Patin, F., Baranek, T., Vourc’h, P., Nadal‐Desbarats, L., Goossens, J., Marouillat, S., Dessein, A., Descat, A., Hounoum, B. M., Bruno, C., et al. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0461-3 · Cited by 41
Crisafulli, S. G., Brajkovic, S., Mis, M. S. C., Parente, V., & Corti, S. P. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0532-4 · Cited by 41
Felice, B. D., Manfellotto, F., Fiorentino, G., Annunziata, A., Biffali, E., Pannone, R., & Federico, A. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00310 · Cited by 41
Eitan, C., Siany, A., Barkan, E., Olender, T., van Eijk, K. R., Moisse, M., Farhan, S. M. K., Danino, Y. M., Yanowski, E., Marmor-Kollet, H., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01040-6 · Cited by 38
Stranahan, A. M., Guo, D., Yamamoto, M., Hernandez, C. M., Khodadadi, H., Baban, B., Zhi, W., Lei, Y., Lu, X., Ding, K., et al. (2022) · Diabetes · doi:10.2337/db22-0192 · Cited by 40
He, D., Xu, Y. C., Liu, M., & Cui, L. (2023) · Aging and Disease · doi:10.14336/ad.2023.0519 · Cited by 44
Terry, R. L., Deffrasnes, C., Getts, D. R., Minten, C., van Vreden, C., Ashhurst, T. M., Getts, M. T., Xie, R. D. V., Campbell, I. L., & King, N. J. C. (2015) · Journal of Innate Immunity · doi:10.1159/000365972 · Cited by 40
Hu, P., Hunt, N. H., Arfuso, F., Shaw, L. C., Uddin, M. N., Zhu, M., Devasahayam, R. N., Adamson, S. J., Benson, V. L., Chan‐Ling, T., et al. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-21654 · Cited by 41
Rusconi, M., Gerardi, F., Santus, W., Lizio, A., Sansone, V., Lunetta, C., Zanoni, I., & Granucci, F. (2017) · Scientific Reports · doi:10.1038/s41598-017-08233-1 · Cited by 40
Melero‐Jerez, C., Suardíaz, M., Lebrón‐Galán, R., Marín-Bañasco, C., Oliver‐Martos, B., Machín-Díaz, I., Fernández, Ó., de Castro, F., & Clemente, D. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.02.014 · Cited by 40
Xing, Z., Zuo, Z., Hu, D., Zheng, X., Wang, X., Yuan, L., Zhou, L., Qi, F., & Yao, Z. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.09.015 · Cited by 38
Goyal, N., & Mozaffar, T. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.933807 · Cited by 40
Kawaguchi, M., Yamamoto, T., Kato, Y., Inose, Y., & Shibata, N. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-21 · Cited by 39
Komiya, H., Takeuchi, H., Ogawa, Y., Hatooka, Y., Takahashi, K., Katsumoto, A., Kubota, S., Nakamura, H., Kunii, M., Tada, M., et al. (2020) · Molecular Brain · doi:10.1186/s13041-020-00607-3 · Cited by 38
Pozzi, S., Codron, P., Soucy, G., Renaud, L., Cordeau, P., Dutta, K., Bareil, C., & Julien, J. (2020) · JCI Insight · doi:10.1172/jci.insight.140420 · Cited by 38
Lopes, J. R. D., Zhang, X., Mayrink, J., Tatematsu, B. K., Guo, L., LeServe, D. S., Abou‐El‐Hassan, H., Rong, F., Dalton, M. J., Oliveira, M. G., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2309221120 · Cited by 38
Self-citationClinical Trial Designs in Amyotrophic Lateral Sclerosis: Does One Design Fit All?
Nicholson, K. A., Cudkowicz, M., & Berry, J. D. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0341-2 · Cited by 37
Self-citationA pilot trial of RNS60 in amyotrophic lateral sclerosis
Paganoni, S., Alshikho, M. J., Luppino, S. D., Chan, J. G. M., Pothier, L. M., Schoenfeld, D., Andres, P. L., Babu, S., Zürcher, N. R., Loggia, M. L., et al. (2018) · Muscle & Nerve · doi:10.1002/mus.26385 · Cited by 39
Self-citationGuo, D., Yamamoto, M., Hernandez, C. M., Khodadadi, H., Baban, B., & Stranahan, A. M. (2021) · Nature Communications · doi:10.1038/s41467-021-24540-8 · Cited by 38
The plasticity of inflammatory monocyte responses to the inflamed central nervous system
Ashhurst, T. M., van Vreden, C., Niewold, P., & King, N. J. C. (2014) · Cellular Immunology · doi:10.1016/j.cellimm.2014.07.002 · Cited by 37
Zhao, W., Beers, D. R., Thonhoff, J. R., Thome, A. D., Faridar, A., Wang, J., Wen, S., Ornelas, L., Sareen, D., Goodridge, H. S., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101192 · Cited by 40
Aslani, M., Mortazavi‐Jahromi, S. S., & Mirshafiey, A. (2021) · Immunology Letters · doi:10.1016/j.imlet.2021.07.004 · Cited by 36
Miller, R. G., Zhang, R., Bracci, P. M., Azhir, A., Barohn, R. J., Bedlack, R., Benatar, M. G., Berry, J. D., Cudkowicz, M., Kasarskis, E. J., et al. (2022) · Muscle & Nerve · doi:10.1002/mus.27511 · Cited by 33
Self-citationFigueroa‐Romero, C., Monteagudo, A., Murdock, B. J., Famie, J. P., Webber‐Davis, I. F., Piecuch, C. E., Teener, S. J., Pacut, C. M., Goutman, S. A., & Feldman, E. L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.773288 · Cited by 35
The role of peripheral immunity in ALS: a population‐based study
Grassano, M., Manera, U., Marchi, F. D., Cugnasco, P., Matteoni, E., Daviddi, M., Solero, L., Bombaci, A., Palumbo, F., Vasta, R., et al. (2023) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51853 · Cited by 34
Significance of aberrant glial cell phenotypes in pathophysiology of amyotrophic lateral sclerosis
Trías, E., Ibarburu, S., Barreto‐Núñez, R., & Barbeito, L. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.07.052 · Cited by 39
Rizzuti, M., Melzi, V., Gagliardi, D., Resnati, D., Meneri, M., Dioni, L., Masrori, P., Hersmus, N., Poesen, K., Locatelli, M., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04217-1 · Cited by 34
Additive amelioration of ALS by co‐targeting independent pathogenic mechanisms
Frakes, A. E., Braun, L., Ferraiuolo, L., Guttridge, D. C., & Kaspar, B. K. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.375 · Cited by 36
Functional microglia neurotransmitters in amyotrophic lateral sclerosis
Volonté, C., Amadio, S., Fabbrizio, P., & Apolloni, S. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.04.014 · Cited by 34
Daneshafrooz, N., Joghataei, M. T., Mehdizadeh, M., Alavi, A., Barati, M., Panahi, B., Teimourian, S., & Zamani, B. (2022) · Scientific Reports · doi:10.1038/s41598-022-05067-4 · Cited by 33
MotomiRs: miRNAs in Motor Neuron Function and Disease
Hawley, Z. C. E., Campos‐Melo, D., Droppelmann, C. A., & Strong, M. J. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00127 · Cited by 34
Pramotton, F. M., Spitz, S., & Kamm, R. D. (2024) · Advanced Science · doi:10.1002/advs.202403892 · Cited by 33
Lanser, A. J., Rezende, R. M., Rubino, S. J., Lorello, P. J., Donnelly, D. J., Xu, H., Lau, L. A., Dulla, C. G., Caldarone, B. J., Robson, S. C., et al. (2017) · Immunology · doi:10.1111/imm.12798 · Cited by 32
Self-citationKobayashi, Y., Inagawa, H., Kohchi, C., Kazumura, K., Tsuchiya, H., Miwa, T., Okazaki, K., & Soma, G. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198493 · Cited by 32
RNA Deregulation in Amyotrophic Lateral Sclerosis: The Noncoding Perspective
Laneve, P., Tollis, P., & Caffarelli, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910285 · Cited by 32
Hu, P., Thinschmidt, J. S., Caballero, S., Adamson, S. J., Cole, L., Chan‐Ling, T., & Grant, M. B. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00504.2014 · Cited by 31
Costello, D. A., Keenan, K., McManus, R. M., Falvey, A., & Lynch, M. A. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.04.001 · Cited by 33
Fazeli, S., Motovali-Bashi, M., Peymani, M., Hashemi, M., Etemadifar, M., Nasr‐Esfahani, M. H., & Ghaedi, K. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240855 · Cited by 30
Liu, E., Karpf, L., & Bohl, D. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.767041 · Cited by 32
The retinal pigment epithelium as a gateway for monocyte trafficking into the eye
Benhar, I., Reemst, K., Kalchenko, V., & Schwartz, M. (2016) · The EMBO Journal · doi:10.15252/embj.201694202 · Cited by 31
Jiang, Z., Chen, Z., Li, L., Zhou, W., & Zhu, L. (2017) · Respiratory Research · doi:10.1186/s12931-017-0707-6 · Cited by 31
The Inflammatory Bridge Between Type 2 Diabetes and Neurodegeneration: A Molecular Perspective
Kacem, H., d’Angelo, M., Qosja, E., Topi, S., Castelli, V., & Cimini, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157566 · Cited by 35
Diagnostic and prognostic values of PBMC proteins in amyotrophic lateral sclerosis
Luotti, S., Pasetto, L., Porcu, L., Torri, V., Elezgarai, S. R., Pantalone, S., Filareti, M., Corbo, M., Lunetta, C., Mora, G., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104815 · Cited by 32
Immunology of amyotrophic lateral sclerosis – role of the innate and adaptive immunity
Mimic, S., Aru, B., Pehlivanoğlu, C., Sleiman, H., Anđjus, P. R., & Demirel, G. Y. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1277399 · Cited by 29
The blood biomarkers puzzle – A review of protein biomarkers in neurodegenerative diseases
Barro, C., & Zetterberg, H. (2021) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2021.109281 · Cited by 30
Trolese, M. C., Scarpa, C., Melfi, V., Fabbrizio, P., Sironi, F. M., Rossi, M., Bendotti, C., & Nardo, G. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.04.018 · Cited by 27
Status of ALS treatment, insights into therapeutic challenges and dilemmas
Khamaysa, M., & Pradat, P.-F. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12101601 · Cited by 28
HDACi delivery reprograms tumor-infiltrating myeloid cells to eliminate antigen-loss variants
Nguyen, A., Ho, L., Workenhe, S. T., Chen, L., Samson, J., Walsh, S. R., Pol, J., Bramson, J. L., & Wan, Y. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.040 · Cited by 29
Non-coding RNAs and neuroinflammation: implications for neurological disorders
Chen, Y., Mateski, J., Gerace, L., Wheeler, J., Burl, J., Prakash, B., Svedin, C., Amrick, R., & Adams, B. D. (2024) · Experimental Biology and Medicine · doi:10.3389/ebm.2024.10120 · Cited by 31
Genetic Association between Amyotrophic Lateral Sclerosis and Cancer
Taguchi, Y., & Wang, H. (2017) · Genes · doi:10.3390/genes8100243 · Cited by 28
Carata, E., Muci, M., Giulio, S. D., Mariano, S., & Panzarini, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411251 · Cited by 30
Microglial crosstalk with astrocytes and immune cells in amyotrophic lateral sclerosis
Calafatti, M., Cocozza, G., Limatola, C., & Garofalo, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1223096 · Cited by 29
Ritzel, R. M., Pan, S. J., Verma, R., Wizeman, J. W., Crapser, J. D., Patel, A. R., Lieberman, R., Mohan, R., & McCullough, L. D. (2016) · PubMed Central · Cited by 28
Lessons Learned about Neurodegeneration from Microglia and Monocyte Depletion Studies
Lund, H., Pieber, M., & Harris, R. A. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00234 · Cited by 27
Marco, G. D., Lomartire, A., Calvo, A., Risso, A., Luca, E. D., Mostert, M., Mandrioli, J., Caponnetto, C., Borghero, G., Manera, U., et al. (2016) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12328 · Cited by 30
Regulation of Skeletal Muscle Development and Disease by microRNAs
Liu, N., & Bassel‐Duby, R. (2014) · Results and problems in cell differentiation · doi:10.1007/978-3-662-44608-9_8 · Cited by 29
Circulating microRNAs in Neurodegenerative Diseases
Grasso, M., Piscopo, P., Crestini, A., Confaloni, A., & Denti, M. A. (2015) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-0348-0955-9_7 · Cited by 26
Solomonov, Y., Hadad, N., & Lévy, R. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0602-y · Cited by 27
Campello, L., Kutsyr, O., Noailles, A., Michalska, P., Fernández‐Sánchez, L., Martínez‐Gil, N., Ortuño‐Lizarán, I., Sánchez‐Sáez, X., de Juan, E., Lax, P., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.33594/000000210 · Cited by 26
Kaur, K., Chen, P., Ko, M.-W., Mei, A., Chovatiya, N., Huerta‐Yépez, S., Ni, W., Mackay, S., Zhou, J., Maharaj, D., et al. (2022) · Cells · doi:10.3390/cells11213431 · Cited by 26
Elevated NLRP3 Inflammasome Activation Is Associated with Motor Neuron Degeneration in ALS
Cihankaya, H., Bader, V., Winklhofer, K. F., Vorgerd, M., Matschke, J., Stahlke, S., Theiß, C., & Matschke, V. (2024) · Cells · doi:10.3390/cells13120995 · Cited by 28
Telomerase reverse transcriptase and neurodegenerative diseases
Yu, X., Liu, M., Zheng, C., Liu, Y., Wang, Z., & Wang, Z.-Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1165632 · Cited by 25
Hanger, B., Couch, A. C. M., Rajendran, L., Srivastava, D. P., & Vernon, A. C. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00789 · Cited by 23
Muth, C., Schröck, K., Madore, C., Hartmann, K., Fanek, Z., Butovsky, O., Glatzel, M., & Krasemann, S. (2017) · Brain Pathology · doi:10.1111/bpa.12441 · Cited by 23
Self-citationLake, J., Storm, C. S., Makarious, M. B., & Bandrés‐Ciga, S. (2021) · Cells · doi:10.3390/cells10051030 · Cited by 24
Sublethal enteroviral infection exacerbates disease progression in an ALS mouse model
Xue, Y. C., Liu, H., Mohamud, Y., Bahreyni, A., Zhang, J., Cashman, N. R., & Luo, H. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02380-7 · Cited by 24
Deng, B., Lv, W., Duan, W., Liu, Y., Li, Z., Song, X., Cui, C., Qi, X., Wang, X., & Li, C. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27105 · Cited by 24
Yang, X., Zheng, J., Tian, S., Chen, Y., An, R., Zhao, Q., & Xu, Y. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.12.055 · Cited by 24
Koeniger, T., & Küerten, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102072 · Cited by 22
Santiago, J. A., Quinn, J. P., & Potashkin, J. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137150 · Cited by 21
Hu, H., Xue, Y., He, Y., Duan, C., & Sun, N. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02569-w · Cited by 20
Ashraf, H., Solla, P., & Sechi, L. A. (2022) · Pharmaceuticals · doi:10.3390/ph15091077 · Cited by 23
MicroRNAs and Molecular Mechanisms of Neurodegeneration
Bicchi, I., Morena, F., Montesano, S., Polidoro, M., & Martino, S. (2013) · Genes · doi:10.3390/genes4020244 · Cited by 23
Davies, C. L., & Miron, V. E. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.06.016 · Cited by 24
Metadata
- Authors
- Butovsky, O., Siddiqui, S., Gabriely, G., Lanser, A. J., Dake, B., Murugaiyan, G., Doykan, C. E., Wu, P. M., Gali, R. R., Iyer, L. K., Lawson, R., Berry, J., Krichevsky, A. M., Cudkowicz, M. E., & Weiner, H. L.
- Affiliations
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Tufts University (US)
- Corresponding author
- Weiner, Howard L.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2012-09-04
- Volume
- 122
- Issue
- 9
- Pages
- 3063-3087
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3428086
- OpenAlex
- W2119656827
- Cited by
- 481
- References
- 81
- Citations by year
- 2026: 6 · 2025: 18 · 2024: 23 · 2023: 32 · 2022: 41 · 2021: 35 · 2020: 46 · 2019: 23 · 2018: 35 · 2017: 47 · 2016: 50 · 2015: 46 · 2014: 42 · 2013: 28 · 2012: 7
- FWCI
- 25.62
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- ALS Association
- Harvard NeuroDiscovery Center
- Brigham and Women's Hospital
- National Institutes of Health
- Center for Neuroscience Research (P30 NS047243)
- National Institute on Aging (AG027437, R01AG027437)
- National Institute of Neurological Disorders and Stroke (P30NS047243, R01NS088137)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Keywords
- amyotrophic lateral sclerosis, inflammatory monocytes, microRNA signature, innate immunity, microglia, monocyte recruitment, spinal cord, CCR2, MCP-1, Ly6C, macrophage polarization, neuronal loss, disease biomarkers, therapeutic target
- MeSH terms
- Superoxide Dismutase-1, Amyotrophic Lateral Sclerosis, Animals, Antibodies, Monoclonal, Antigens, Ly, Apyrase, Chemotaxis, Female, Humans, Male, Mice, Inbred C57BL, Mice, Transgenic, Monocytes, Rats, Inbred Lew, Spinal Cord, Spleen, Superoxide Dismutase, Transcription Factors, Antigens, CD, Macrophages, Alveolar, Apoptosis, Microglia, Inflammation Mediators, Oligonucleotide Array Sequence Analysis, RNA Interference, MicroRNAs, Cell Proliferation, Mice, Rats, Gene Regulatory Networks, Metabolic Networks and Pathways, Immunomodulation, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review